49 studies found for:    "epidermolysis bullosa simplex" OR "Epidermolysis Bullosa"
Show Display Options
Rank Status Study
1 Completed Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara
Condition: Epidermolysis Bullosa Simplex Dowling Meara
Intervention: Procedure: Taking of liquid and top of blisters
2 Not yet recruiting Diacerin for the Treatment of Epidermolysis Bullosa Simplex
Condition: Epidermolysis Bullosa Simplex
Intervention: Drug: Diacerin cream
3 Unknown  Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita
Condition: Epidermolysis Bullosa Simplex
Interventions: Drug: Dysport® (Botulinumtoxin A (Btx A));   Drug: Placebo
4 Unknown  Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
Condition: Epidermolysis Bullosa
Intervention: Drug: Oral erythromycin
5 Recruiting Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
Conditions: Epidermolysis Bullosa Simplex;   Pachyonychia Congenita
Interventions: Drug: Jojoba oil with broccoli sprout extract;   Drug: Jojoba oil (placebo)
6 Recruiting Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Intervention: Genetic: LZRSE-Col7A1 Engineered Autologous Epidermal Sheets (LEAES)
7 Terminated
Has Results
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Conditions: Epidermolysis Bullosa, Junctional;   Epidermolysis Bullosa Dystrophica
Interventions: Device: Apligraf;   Other: Standard dressing regimen
8 Completed
Has Results
Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care
Conditions: Epidermolysis Bullosa Dystrophica;   Epidermolysis Bullosa
Interventions: Device: Helicoll;   Device: Standard of Care Dressings
9 Withdrawn Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
10 Unknown  Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa
Intervention: Drug: Reduced Intensity Transplant conditioning
11 Recruiting Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Other: Allogeneic mesenchymal stem cells
12 Withdrawn A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Biological: HP802-247;   Other: Placebo
13 Terminated
Has Results
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic bone marrow transplantation
14 Completed
Has Results
Study of Alwextin® Cream in Treating Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Alwextin cream
15 Recruiting Study of Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: SD-101-6.0 cream;   Drug: SD-101-0.0 cream
16 Active, not recruiting Open Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: SD-101 dermal cream (6%)
17 Completed The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Trimethoprim
18 Completed Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: 3% SD-101 dermal cream;   Drug: 6% SD-101 dermal cream;   Drug: Vehicle (0% SD-101)
19 Terminated
Has Results
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: Thymosin Beta 4;   Drug: Placebo
20 Active, not recruiting Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Zorblisa (SD-101-6.0) cream

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years